Clinicians Rejuvenate with Hyaluronic Acid is a high quality Women's Beauty formula which helps reduce the physical signs of aging

Clinicians Rejuvenate with Hyaluronic acid contains ingredients that work synergistically to provide the building blocks for your body's synthesis of skin collagen. Rejuvenate is for skin elasticity and plumpness, skin hydration, collagen repair and Luscious hair and healthy nails.

Benefits
Contains a synergistic combination of natural collagen and hyaluronic acid to strengthen, lubricate and hydrate the skin
It helps provide skin elasticity
Hydrates and plumps the skin
Repairs collagen and reduces the appearance of fine lines, wrinkles and age spots
Astaxanthin helps protect against UV damage
Astaxanthin is a powerful antioxidant proven to enhance skin appearance by reducing the appearance of wrinkles and helps improve skin elasticity.
Avocado oil helps increase the bioavailability and absorption of astaxanthin
Both the New Zealand marine collagen and astaxanthin are derived from sustainable resources
And it offers the added benefit of delivering luscious hair and nails


Features

Contains New Zealand marine collagen and hyaluronic acid
Contains New Zealand astaxanthin
Includes New Zealand avocado oil
Made from sustainable resources

Adults: Take 2 capsules daily for 8 weeks, thereafter reduce to 1 capsule daily.

Active Ingredients in each softgel capsule:

New Zealand marine collagen 250 mg

Hyaluronic acid 25 mg

Astaxanthin 3 mg

New Zealand avocado oil 465 mg

Also contains : Gelatine, glycerol and water, sorbitol, beeswax, titanium dioxide and iron oxide.

No added: Gluten, dairy, yeast, sugar, artificial colours, sweeteners, flavours or preservatives.

Theoretically avocado oil may affect bleeding times. Exercise caution with people taking blood thinning medication and monitor coagulation levels particularly during the first month of supplementation
Pregnancy and Breastfeeding - Exercise caution or avoid during pregnancy and breast feeding due to the astaxanthin content. Due to a lack of safety data in this cohort